Researchers may have found a new target in chronic obstructive pulmonary disease (COPD) symptoms that could potentially save more lives. The study focused on mucus plugs, which clog airways in the ...

A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease—the fourth leading cause of ...

A retrospective analysis of data of patients with chronic obstructive pulmonary disease (COPD) suggests that mucus plugs could contribute to patient mortality, offering a possible treatment target.

Please provide your email address to receive an email when new articles are posted on . More adults with COPD and mucus plugs died vs. adults with COPD and no mucus plugs. A heightened mortality risk ...

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading cause of death. Mucus plugging (mucus that accumulates in the lungs and ...

WASHINGTON -- Mucus plugs obstructing the airways of patients with chronic obstructive pulmonary disease (COPD) were associated with higher all-cause mortality compared with no mucus plugs, according ...

Please provide your email address to receive an email when new articles are posted on . Researchers found a link between mucus plugs in at least three lung segments and respiratory and cancer ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...

A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease - the fourth leading cause of ...

Flutter valves are handheld devices that help people with chronic obstructive pulmonary disease (COPD) clear excess mucus from their airways. They work by combining positive expiratory pressure with ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...